State Street Corp Jaguar Health, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.08 - $5.43 $11,227 - $762,035
-140,338 Closed
0 $0
Q2 2022

Aug 15, 2022
BUY
$0.27 - $0.71 $2,295 - $6,035
8,500 Added 6.45%
140,338 $41,000
Q3 2021

Nov 15, 2021
BUY
$2.14 - $4.95 $282,133 - $652,598
131,838 New
131,838 $299,000

Others Institutions Holding JAGX

# of Institutions
2
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Jaguar Health, Inc.

JAGX Quotes by TradingView
  • Ticker JAGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,861,000
  • Market Cap $117M
  • Description
  • Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...
More about JAGX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email